Detailansicht
Targeted Therapeutics in Melanoma
Current Clinical Oncology
ISBN/EAN: 9781617794063
Umbreit-Nr.: 1512406
Sprache:
Englisch
Umfang: xiv, 378 S.
Format in cm:
Einband:
gebundenes Buch
Erschienen am 14.12.2011
Auflage: 1/2012
- Zusatztext
- Melanoma is an increasingly important public health problem. Although the cause of most malignant melanomas - over-exposure to ultraviolet light - is well known, effective treatment has remained challenging.The past several years have been marked by extraordinary developments in melanoma treatment in the arena of targeted therapeutics. This book describes these ground-breaking discoveries and their implications for clinical use. As melanoma biology is increasingly understood, so the development of targeted therapies for this disease is spurred ahead. This book covers both established signal transduction inhibitors and the fascinating emerging realm of molecularly-guided immunotherapies.This benchmark book provides the most up-to-date information on the new breed of melanoma therapies. Composed of the works of major researchers and clinicians, this book offers new insights, novel approaches, and promising data for effective treatment planning. Illuminating the latest advances in the field, it is a solid resource for clinical oncologists, translational scientists, and basic cancer researchers.
- Kurztext
- Describes both established signal transduction inhibitors as well as emerging molecularly-guided immunotherapiesPlaces exciting developments in basic biological understanding into a practical clinical contextThe first book on melanoma devoted entirely to targeted therapeuticsIncludes the most up-to-date data from current clinical Phase I-III trialsWritten by high-profile authors representing the worlds leaders in their fieldIncludes supplementary material: sn.pub/extras